News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
A year of discovery: Looking back at 2025 and ahead to 2026
In 2025, RECOVER’s progress included closing the first phase of its adult observational study and publishing its first clinical trial results. This year, the initiative continues its studies and sharing research findings.
Feature
147 Results
147 Results
R3 Seminar Recap: Long COVID in older adults: Insights from the RECOVER adult observational cohort
During the October 28 RECOVER Research Review (R3) seminar, RECOVER researchers Samantha Russell, MD, and Janko Nikolich, MD, PhD, MSc, presented their published papers on Long COVID in older adults. Dr. Russell discussed a review article on Long COVID in older adults, which was published in 2024. Dr. Nikolich shared findings from the RECOVER observational study that compared Long COVID symptoms across different age groups. Quinn Barnette, MPH, facilitated the discussion.
R3 Seminar Recap
RECOVER-NEURO clinical trial shares results of three non-drug treatments for cognitive symptoms of Long COVID
Results from the RECOVER-NEURO clinical trial were published in the journal JAMA Neurology. The trial focused on symptoms of cognitive dysfunction associated with Long COVID, including brain fog, trouble focusing, and thinking clearly.
News Release
RECOVER biosamples and data advance understanding of what may cause Long COVID
RECOVER pathobiologists have designed a large, collaborative, and innovative study that can help to develop diagnostics for specific types of Long COVID.
Feature
Mother and daughter RECOVER Representatives share their journey of recovery, caregiving, and advocacy
A mother living with Long COVID and her daughter, who supports her as a caregiver, share their motivations to join the RECOVER Initiative as Representatives.
Feature
Building trust and community: How top clinical trial sites excel in RECOVER enrollment success
Teams from 4 RECOVER clinical trial sites share their recruitment strategies and their efforts to reach out to and share research opportunities with their local communities.
Feature
R3 Seminar Recap: Social determinants of health and Long COVID: Insights from the RECOVER observational studies
During the RECOVER Research Review (R3) Seminar on October 14, RECOVER researchers Candace Feldman, MD, MPH, ScD, and Kay Rhee, MD, MSc, MA, shared new findings from the initiative’s adult and pediatric observational studies about how social and economic challenges influence the risk of developing Long COVID. RECOVER Representative and coauthor of the adult study paper, Brittany D. Taylor, MPH, joined them to share her experience in collaborating with the paper’s other authors. Elizabeth Karlson, MD, MS, who was also a coauthor of the adult study paper, facilitated the discussion and Q&A session.
R3 Seminar Recap
Upcoming seminars will highlight available tools to explore and analyze RECOVER data
RECOVER researchers and experts from BioData Catalyst® will walk through tools that other researchers may use for their studies of RECOVER data, from determining feasibility to completing the study.
Feature
Electronic health records are an important tool to address Long COVID questions
Electronic health records (EHRs) give researchers the ability to look at large groups of people and understand how Long COVID behaves over a long period of time.
Feature